» Articles » PMID: 16925311

Predictive Factors of Thromboembolic Events in Patients Undergoing Roux-en-Y Gastric Bypass

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2006 Aug 24
PMID 16925311
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity is a major risk factor for postoperative deep venous thrombosis (DVT) and pulmonary embolism (PE). Identifying those patients at the greatest risk for DVT/PE is essential to prevent thromboembolic events among patients undergoing Roux-en-Y gastric bypass (RYGB) for clinically significant obesity. This aim of the study is to identify factors associated with an increased likelihood of developing DVT/PE after RYGB.

Methods: Prospectively collected data from 660 consecutive patients who underwent RYGB were reviewed. Patients received perioperative prophylaxis with low molecular weight heparin and sequential compression devices. Diagnosis was based on clinical, radiologic, and/or necropsy findings. Patients with and without postoperative DVT/PE were compared using chi(2) and multivariate logistic regression analysis.

Results: A total of 23 patients (3.5%) developed postoperative DVT/PE. Age > 50 years (P = .04), previous DVT/PE (P = .02), history of smoking (P < .01), revisional operation (P = .03), open RYGB (P = .02), and anastomotic leak (P < .0001) significantly increased the likelihood of developing DVT/PE. On the other hand, gender, body mass index > 50 kg/m(2) and history of sleep apnea, hypertension, diabetes, or myocardial infarction did not increase the likelihood of DVT/PE. Multivariate analysis revealed that age > 50 years (P = .04), postoperative anastomotic leak (P < .001), smoking (P < .01), and previous DVT/PE (P < .001) increased the likelihood of postoperative DVT/PE.

Conclusions: Age > 50 years, anastomotic leak, smoking, and history of DVT/PE all increase the likelihood of postoperative thromboembolic events in patients undergoing RYGB. Further preoperative screening and/or postoperative prophylaxis may be needed in this subset of high-risk patients.

Citing Articles

Integrated Insights into Metabolic and Bariatric Surgery: Improving Life Quality and Reducing Mortality in Obesity.

Marin R, Radu A, Negru P, Radu A, Negru D, Aron R Medicina (Kaunas). 2025; 61(1).

PMID: 39858996 PMC: 11767230. DOI: 10.3390/medicina61010014.


The clinical effect of endoscopic and open surgery in the treatment of thyroid cancer and their effect on the blood coagulation state: a comparative study.

Xu Q, Zhu L, Chen W, Peng W Ann Surg Treat Res. 2024; 107(3):127-135.

PMID: 39282099 PMC: 11390278. DOI: 10.4174/astr.2024.107.3.127.


Cumulative Incidence of Venous Thromboembolic Events In-Hospital, and at 1, 3, 6, and 12 Months After Metabolic and Bariatric Surgery: Systematic Review of 87 Studies and Meta-analysis of 2,731,797 Patients.

El Ansari W, El-Menyar A, El-Ansari K, Al-Ansari A, Lock M Obes Surg. 2024; 34(6):2154-2176.

PMID: 38602603 PMC: 11127857. DOI: 10.1007/s11695-024-07184-7.


Recent advances in bariatric surgery: a narrative review of weight loss procedures.

Aderinto N, Olatunji G, Kokori E, Olaniyi P, Isarinade T, Yusuf I Ann Med Surg (Lond). 2023; 85(12):6091-6104.

PMID: 38098582 PMC: 10718334. DOI: 10.1097/MS9.0000000000001472.


Smoking in bariatric surgery: a systematic review.

Chow A, Neville A, Kolozsvari N Surg Endosc. 2020; 35(6):3047-3066.

PMID: 32524412 DOI: 10.1007/s00464-020-07669-3.